Gastric Adenocarcinoma Quiz
40 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is one of the main risk factors for gastric adenocarcinoma?

  • Helicobacter pylori infection (correct)
  • Obesity
  • High salt diet
  • Smoking
  • What is a significant challenge in the prognosis of gastric adenocarcinoma?

  • Late stage of diagnosis. (correct)
  • Effective vaccination is unavailable.
  • Limited access to treatment.
  • Lack of symptoms in early stages.
  • Which condition is characterized by the presence of gastric intestinal metaplasia (GIM)?

  • Pernicious anemia
  • Chronic gastritis
  • Dysplasia (correct)
  • Gastric atrophy
  • What is the role of the British Society of Gastroenterology (BSG) endoscopy committee concerning gastric adenocarcinoma?

    <p>To create guidelines for diagnosis and management.</p> Signup and view all the answers

    Which is a prerequisite condition leading to gastric adenocarcinoma?

    <p>Chronic gastritis</p> Signup and view all the answers

    What is considered an efficacious treatment to intervene in the progression of gastric cancer?

    <p>Endoscopic resection</p> Signup and view all the answers

    Which hereditary condition is mentioned as a risk factor for gastric cancer?

    <p>Hereditary diffuse gastric cancer</p> Signup and view all the answers

    What is a consequence of the late-stage diagnosis of gastric adenocarcinoma?

    <p>Lower rates of patient survival.</p> Signup and view all the answers

    What are the primary conditions associated with gastric adenocarcinoma?

    <p>Gastric atrophy and gastric intestinal metaplasia</p> Signup and view all the answers

    What is a common cause of chronic atrophic gastritis (CAG)?

    <p>Helicobacter pylori infection</p> Signup and view all the answers

    Which procedure is recommended for patients at higher risk of gastric adenocarcinoma?

    <p>Full systematic endoscopy protocol</p> Signup and view all the answers

    What is the suggested follow-up for patients after an endoscopy if no visible neoplasia is detected?

    <p>Repeat endoscopy within 1 year</p> Signup and view all the answers

    What is the reported accuracy of detecting GA and GIM using white light endoscopy (WLE)?

    <p>Poor accuracy</p> Signup and view all the answers

    What action should be taken if persistent, non-visible low-grade dysplasia (LGD) is found during endoscopy?

    <p>Annual endoscopy should be conducted</p> Signup and view all the answers

    How often should enhanced imaging and extensive biopsy sampling be conducted according to the recommendation?

    <p>At least once per year</p> Signup and view all the answers

    What is the level of agreement regarding the recommended protocol for endoscopy in at-risk patients?

    <p>100%</p> Signup and view all the answers

    What is the recommended imaging modality for accurately detecting and risk-stratifying GA and GIM?

    <p>Image-enhanced endoscopy (IEE)</p> Signup and view all the answers

    What is the recommended action for patients with non-visible, high-grade dysplasia (HGD)?

    <p>Immediate second endoscopy with enhanced imaging</p> Signup and view all the answers

    Which technique is specifically recommended for ensuring en bloc excision of lesions greater than 10 mm?

    <p>Endoscopic submucosal dissection (ESD)</p> Signup and view all the answers

    What should be discussed at the regional upper GI cancer multidisciplinary team for endoscopic appearances suggestive of GA or GIM?

    <p>Escalation to high-resolution IEE</p> Signup and view all the answers

    How should gastric dysplasia and early gastric adenocarcinoma be treated?

    <p>With en bloc resection</p> Signup and view all the answers

    What is the principal patient group targeted for non-invasive identification before endoscopy?

    <p>Patients with chronic atrophic gastritis</p> Signup and view all the answers

    What type of endoscopic grading should be documented for GA and GIM?

    <p>Location and extent with photographic evidence</p> Signup and view all the answers

    Which method is emphasized for the best detection and risk stratification of gastric adenocarcinoma?

    <p>Image-enhanced endoscopy and biopsy sampling</p> Signup and view all the answers

    What is the level of agreement for recommending ongoing surveillance at 6-month intervals for persistent, non-visible HGD?

    <p>100%</p> Signup and view all the answers

    What does the Sydney protocol guide regarding biopsies?

    <p>Biopsies should be directed to areas of visualized gastric abnormalities</p> Signup and view all the answers

    How is endoscopic grading classified based on location for gastric lesions?

    <p>Proximal gastric (high risk) vs. distal gastric (low risk)</p> Signup and view all the answers

    What is the stance on using biomarkers for population screening of gastric conditions?

    <p>They are useful but not sufficiently supported for screening</p> Signup and view all the answers

    Which group of professionals are the target users for the guidelines discussed?

    <p>Gastroenterologists and GI surgeons</p> Signup and view all the answers

    What is stated about screening in a low-risk population undergoing routine diagnostic procedures?

    <p>There is insufficient evidence to support it</p> Signup and view all the answers

    Which approach is deemed important for improving early detection of gastric conditions?

    <p>High-quality endoscopy with full mucosal visualization</p> Signup and view all the answers

    What quality assessment tool was followed to evaluate the evidence provided in the guidelines?

    <p>The GRADE system</p> Signup and view all the answers

    What is the suggested method of surveillance for patients with extensive gastric adenocarcinoma or gastric intestinal metaplasia?

    <p>Endoscopic surveillance every 3 years</p> Signup and view all the answers

    What is the evidence level for the efficacy of endoscopic mucosal resection or endoscopic submucosal dissection in treating visible gastric dysplasia and early cancer?

    <p>High quality</p> Signup and view all the answers

    What is the grade of recommendation for H.pylori eradication to reduce the risk of gastric adenocarcinoma development?

    <p>Weak</p> Signup and view all the answers

    What is the risk associated with gastric adenocarcinoma globally?

    <p>It is the 16th most common cancer in the UK</p> Signup and view all the answers

    What is the recommendation regarding the use of biomarkers as a screening tool in areas with low incidence?

    <p>They are not recommended</p> Signup and view all the answers

    Which factor enhances the benefit of H.pylori eradication in reducing gastric adenocarcinoma risk?

    <p>Existing H.pylori-associated gastric intestinal metaplasia or dysplasia</p> Signup and view all the answers

    What is the overall success rate of endoscopic mucosal resection when quality criteria are met?

    <p>High success rate and low recurrence</p> Signup and view all the answers

    What recommendation level denotes the agreement for the benefits of H.pylori eradication in reducing the risk of gastric adenocarcinoma?

    <p>Level of agreement: 100%</p> Signup and view all the answers

    Study Notes

    British Society of Gastroenterology Guidelines on Gastric Adenocarcinoma

    • Gastric adenocarcinoma has a poor prognosis, often diagnosed late
    • Risk factors include H. pylori infection, family history (especially hereditary diffuse gastric cancer), and pernicious anaemia
    • Progression to cancer involves chronic gastritis, gastric atrophy, gastric intestinal metaplasia (GIM), and dysplasia
    • Early detection is key for improved survival
    • Biomarkers have insufficient evidence for population screening
    • High-quality endoscopy with full mucosal visualization is crucial for early detection
    • Image-enhanced endoscopy (IEE) with biopsy sampling (Sydney protocol) is the best approach. Biopsy samples from the antrum, incisura, lesser and greater curvatures help diagnose and stratify risk
    • Endoscopic surveillance every 3 years is suggested for patients with extensive gastric atrophy or GIM, but not low risk
    • Endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) of visible dysplasia/early cancer is effective
    • H. pylori eradication is recommended for patients with gastric atrophy (GA) – high quality evidence, high recommendation.
    • H. pylori eradication may be of some benefit for those with H. pylori-associated GIM, dysplasia, or cancer - high quality evidence, weak recommendation
    • Biomarkers are not recommended for screening in areas with low incidence of gastric adenocarcinoma (like the UK) – low quality evidence, weak recommendation
    • Patients with high risk (e.g., GA and GIM) need a full stomach endoscopy protocol with clear photographic documentation

    Diagnosis and Management of Gastric Precancerous Lesions

    • Image-enhanced endoscopy (IEE) is the best method to detect and risk-stratify GA and GIM
    • IEE may need to be escalated to high-resolution IEE or magnification endoscopy for suspicious areas
    • Documentation of location and extent of GA and GIM with photos is essential
    • Distal (low risk) and proximal (high risk) gastric locations should be differentiated
    • All gastric dysplasia and early gastric adenocarcinoma must be resected en bloc- using EMR(lesions ≤10mm) or ESD (lesions >10mm)
    • Complete endoscopic resection (RO) is considered curative for specific conditions (e.g., low-grade dysplasia (LGD), high-grade dysplasia (HGD), specific types and sizes of adenocarcinoma).
    • Features suggestive of higher lymph node metastasis (LNM) risk after endoscopic resection include poorly differentiated submucosal cancer, signet ring cancer, lymphovascular invasion, and submucosal invasion ≥500 µm.
    • NSAIDs and antioxidants are not recommended for reducing gastric precancerous lesion progression.
    • Endoscopic surveillance every 3 years is recommended for patients with extensive GA or GIM; this should be 3 yearly unless other factors raise risk (e.g., family history of gastric cancer or persistent H. pylori infection)
    • Patients with non-visible LGD should undergo a repeat endoscopy with image enhancement and biopsy within a year; and subsequently annually if needed
    • Non-visible HGD needs immediate repeat endoscopy with image enhancement and biopsy. Ongoing 6-monthly surveillance is recommended.
    • Consult with an expert regional upper GI cancer MDT if HGD is present
    • Considering Age, multiple risk factors, and family history when assessing the need for screening

    Surveillance

    • Endoscopic surveillance every 3 years is recommended for patients with extensive GA or GIM, affecting the antrum and body
    • Surveillance is not recommended for those with GA or GIM limited to the antrum, unless additional risk factors (e.g., strong family history of gastric cancer or persistent H. pylori infection) are present
    • Surveillance interval should be adjusted based on the severity and extent of the premalignant conditions
    • The GDG did not agree whether using OLGA or OLGIM routinely in practice, as there is not enough expertise/capacity.

    Biopsies and Biomarker use

    • Biopsies should assess mucosal sites in the Sydney protocol areas if IEE visualization suggests GIM
    • Biopsies should be labelled appropriately (e.g., "directed" or "random")
    • Biopsy should be considered in those aged ≥50 years with laboratory evidence (vitamin B12) deficiency & antibody tests suggesting pernicious anemia
    • Patients whose conditions are not clear need a review by an expert pathologist and repeat image enhanced endoscopy

    Treatment

    • All gastric dysplasia and early gastric adenocarcinoma should be resected en bloc using EMR or ESD
    • Complete (RO) endoscopic resection (using EMR or ESD) is considered curative for certain types of gastric dysplasia and early-stage cancers
    • Patients with ambiguous findings need MDT discussion, and possible referral to an expert center prior to any active treatment
    • Recommendations for treatment are mainly based on the intestinal type of gastric cancer
    • Use ESD over EMR for larger lesions, due to superior resection success rates
    • Surgery should be considered only if endoscopic resection isn't curative or if the patient prefers surgery

    Risk Factors

    • H.pylori infection, family history, pernicious anemia, non-white origin, gastric surgery (for benign conditions) longer than 15 years, age older than 45, high salt intake and smoking are risks for gastric cancer
    • Risk factors should be considered individually when assessing risk
    • Family history of gastric cancer is a strong risk factor.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on gastric adenocarcinoma, its risk factors, and prognosis challenges. This quiz covers important aspects such as hereditary conditions, treatment options, and the role of endoscopy in managing gastric cancer. Delve into the pathophysiology and management strategies associated with this significant health issue.

    More Like This

    Quiz sobre cáncer gástrico
    5 questions
    Signet Ring Cells and Krukenburg Tumor
    34 questions
    Gastric Adenocarcinoma Overview
    24 questions
    Gastric Neoplasms Overview
    30 questions

    Gastric Neoplasms Overview

    EndorsedOrangeTree avatar
    EndorsedOrangeTree
    Use Quizgecko on...
    Browser
    Browser